Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03685591
Title PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Scottsdale Arizona 85258 United States Details
UCLA Dept of Medicine -Hematology/Oncology,Santa Monica Santa Monica California 90404 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Brigham and Women's Hospital Boston Massachusetts 02115 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Mass General/ North Shore Center for Outpatient Care Danvers Massachusetts 01923 United States Details
Dana-Farber Cancer Institute - Chestnut Hill Newton Massachusetts 02459 United States Details
OU Medical Center Presbyterian Tower Oklahoma City Oklahoma 73104 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Sarah Cannon Research Institute - Pharmacy Nashville Tennessee 37203 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
The Sarah Cannon Research Institute / Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
The Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field